GLP-1 receptor agonists may improve outcomes in idiopathic intracranial hypertension
For patients with idiopathic intracranial hypertension (IIH), glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is associated with improved clinical...
Read moreDetails